肿瘤相关巨噬细胞铁死亡在肿瘤免疫逃逸中的作用及其调控机制研究OA
The Role of Tumor-Associated Macrophage Ferroptosis in Tumor Immune Escape and Its Regulatory Mechanisms
目的:基于肿瘤相关巨噬细胞(TAMs)铁死亡在肿瘤免疫逃逸中的作用及其调控机制研究.方法:建立4T1 乳腺癌小鼠模型,分为 BMDMs 组、4T1 CM 处理组、BMDMs+RSL3 组、4T1 CM+RSL3 组和4T1 CM+RSL3+Fer-1 组.通过荧光激活细胞分选(FACS)获取原代 TAMs 并进行 RNA 测序.采用 qRT-PCR、蛋白质印迹、免疫荧光、流式细胞术评估 SLC7A11(xCT)、GPX4 表达、脂质过氧化水平及 M1/M2 表型.通过 CCK-8 法和 Ferrostatin-1 挽救实验验证铁死亡敏感性.在肿瘤小鼠中,评估铁死亡诱导剂 RSL3 对肿瘤生长、免疫细胞浸润(免疫组化/多色免疫荧光)及 CD8+T 细胞功能(流式检测 IFN-γ、Ki-67)的影响.结果:与 BMDMs 相比,TAMs 中 SLC7A11 表达显著上调,且差异基因富集于铁死亡通路(P<0.05).4T1 CM 可时间依赖性地上调 BMDMs 中 SLC7A11 与 GPX4 的表达,并降低其脂质过氧化水平及对 RSL3 的敏感性(P<0.05).4T1 CM 组 M2 样极化(CD206、Arg1 上调,CD86 下调)密切相关(P<0.05).体内实验表明,RSL3 治疗显著抑制肿瘤生长,并重塑免疫微环境:肿瘤内CD4+、CD8+T 细胞及颗粒酶 B+细胞浸润增加,CD8+T 细胞从间质向实质内转移,且与肿瘤细胞(CK19+)共定位增强;同时,肿瘤浸润 CD8+T 细胞的 IFN-γ 分泌与 Ki-67 表达能力显著提升(P<0.05).结论:本研究阐明了 TME 通过上调 SLC7A11/GPX4 轴赋予 TAMs 铁死亡抵抗,进而驱动其向 M2 样免疫抑制表型极化的新机制.靶向逆转 TAMs 的铁死亡抵抗可有效解除其对 CD8+T 细胞的物理隔离与功能抑制,重塑抗肿瘤免疫.
Objective:To investigate the role of ferroptosis in tumor-associated macrophages(TAMs)and its regulatory mechanisms in tumor immune escape.Methods:A 4T1 breast cancer mouse model was es-tablished and divided into the following groups:BMDMs group,4T1 conditioned medium(CM)treatment group,BMDMs+RSL3 group,4T1 CM+RSL3 group,and 4T1 CM+RSL3+Fer-1 group.Primary TAMs were isolated via fluorescence-activated cell sorting(FACS)for RNA sequencing.The expression of SLC7A11(xCT)and GPX4,lipid peroxidation levels,and M1/M2 phenotypes were assessed using qRT-PCR,West-ern blotting,immunofluorescence,and flow cytometry.Ferroptosis sensitivity was validated through CCK-8 assays and Ferrostatin-1 rescue experiments.In tumor-bearing mice,the effects of the ferroptosis inducer RSL3 on tumor growth,immune cell infiltration(immunohistochemistry/multiplex immunofluorescence),and CD8+T cell function(flow cytometry for IFN-γ and Ki-67)were evaluated.Results:Compared to BMDMs,SLC7A11 expression was significantly upregulated in TAMs,and differentially expressed genes were enriched in ferroptosis-related pathways(P<0.05).4T1 CM treatment time-dependently upregulated the expression of SLC7A11 and GPX4 in BMDMs,reduced lipid peroxidation levels,and decreased sensitivity to RSL3(P<0.05).The 4T1 CM-treated group exhibited a close association with M2-like polarization(upregulation of CD206 and Arg1,downregulation of CD86)(P<0.05).In vivo experiments demonstrated that RSL3 treat-ment significantly inhibited tumor growth and remodeled the immune microenvironment:infiltration of CD4+and CD8+T cells and Granzyme B+cells within tumors increased;CD8+T cells shifted from the stroma into the tumor parenchyma and showed enhanced co-localization with tumor cells(CK19+).Concurrently,the tumor-infiltrating CD8+T cells exhibited significantly enhanced abilities to secrete IFN-γ and express Ki-67(P<0.05).Conclusions:This study reveals a novel mechanism by which the tumor microenvironment(TME)con-fers ferroptosis resistance to TAMs by upregulating the SLC7A11/GPX4 axis,thereby driving their polarization towards an M2-like immunosuppressive phenotype.Targeting and reversing ferroptosis resistance in TAMs can effectively alleviate their physical exclusion and functional suppression of CD8+T cells,reshaping the anti-tumor immune response.
康秉南;刘哲;康瀚文;郭志利;杜娇;高凡茸;张瑶琴;张沂洲
石家庄医学高等专科学校,河北 石家庄 050599石家庄医学高等专科学校,河北 石家庄 050599石家庄医学高等专科学校,河北 石家庄 050599石家庄医学高等专科学校,河北 石家庄 050599石家庄医学高等专科学校,河北 石家庄 050599石家庄医学高等专科学校,河北 石家庄 050599石家庄医学高等专科学校,河北 石家庄 050599河北医科大学,河北 石家庄 050011
肿瘤免疫逃逸肿瘤相关巨噬细胞铁死亡SLC7A11/GPX4
Tumor immune escapeTumor-associated macrophagesFerroptosisSLC7A11/GPX4
《河北医学》 2026 (7)
1057-1063,7
河北省自然科学基金资助项目(H2024206135)
评论